SLC2A11

Summary

SLC2A11 (solute carrier family 2 member 11, HGNC:14239) is a protein-coding gene on chromosome 22q11.23, encoding Solute carrier family 2, facilitated glucose transporter member 11 (Q9BYW1). Facilitative glucose transporter.

This gene belongs to a family of proteins that mediate the transport of sugars across the cell membrane. The encoded protein transports glucose and fructose. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 66035 — RefSeq curated summary.

At a glance

• GWAS associations: 2
• Clinical variants (ClinVar): 108 total
• MANE Select transcript: NM_001024939

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:14239
Approved symbol	SLC2A11
Name	solute carrier family 2 member 11
Location	22q11.23
Locus type	gene with protein product
Status	Approved
Aliases	GLUT11
Ensembl gene	ENSG00000133460
Ensembl biotype	protein_coding
OMIM	610367
Entrez	66035

Gene structure

Transcript identifiers

Ensembl transcripts: 27 — 10 protein_coding, 7 retained_intron, 5 nonsense_mediated_decay, 5 protein_coding_CDS_not_defined

ENST00000255830, ENST00000316185, ENST00000345044, ENST00000398356, ENST00000403208, ENST00000405286, ENST00000405340, ENST00000405847, ENST00000418102, ENST00000423972, ENST00000436643, ENST00000440493, ENST00000461809, ENST00000467660, ENST00000472526, ENST00000473357, ENST00000473740, ENST00000482576, ENST00000486907, ENST00000489322, ENST00000491948, ENST00000492516, ENST00000611880, ENST00000947066, ENST00000947067, ENST00000947068, ENST00000947069

RefSeq mRNA: 4 — MANE Select: NM_001024939 NM_001024938, NM_001024939, NM_001282864, NM_030807

CCDS: CCDS13818, CCDS33616, CCDS46673, CCDS74828

Canonical transcript exons

ENST00000316185 — 12 exons

Exon	Start	End
ENSE00001822292	23857875	23858029
ENSE00001832956	23884649	23886312
ENSE00003500933	23877721	23877869
ENSE00003502128	23883949	23884024
ENSE00003549447	23883772	23883873
ENSE00003553444	23884302	23884429
ENSE00003577221	23882459	23882646
ENSE00003580882	23877042	23877171
ENSE00003612609	23882759	23882869
ENSE00003629303	23862104	23862202
ENSE00003674675	23875117	23875241
ENSE00003682329	23868481	23868641

Expression profiles

Bgee: expression breadth ubiquitous, 141 present calls, max score 94.55.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.6050 / max 200.0992, expressed in 1772 samples.

FANTOM5 promoters (9 alternative TSS)

Promoter ID	TPM avg	Samples expressed
191340	7.5593	1669
191341	5.4783	1617
191334	0.9412	454
191339	0.7663	405
191337	0.2640	116
191333	0.2590	91
191335	0.1364	45
191338	0.1292	39
191332	0.0714	16

Top tissues by expression

144 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
right hemisphere of cerebellum	UBERON:0014890	94.55	gold quality
cerebellar hemisphere	UBERON:0002245	94.32	gold quality
cerebellar cortex	UBERON:0002129	94.27	gold quality
cerebellum	UBERON:0002037	94.23	gold quality
metanephros cortex	UBERON:0010533	93.86	gold quality
sural nerve	UBERON:0015488	92.49	gold quality
apex of heart	UBERON:0002098	91.69	gold quality
pituitary gland	UBERON:0000007	91.68	gold quality
cortex of kidney	UBERON:0001225	91.21	gold quality
body of pancreas	UBERON:0001150	91.09	gold quality
nucleus accumbens	UBERON:0001882	90.60	gold quality
adenohypophysis	UBERON:0002196	90.44	gold quality
heart left ventricle	UBERON:0002084	89.65	gold quality
hypothalamus	UBERON:0001898	89.57	gold quality
adult mammalian kidney	UBERON:0000082	89.29	gold quality
primary visual cortex	UBERON:0002436	89.21	gold quality
right frontal lobe	UBERON:0002810	89.08	gold quality
brain	UBERON:0000955	89.03	gold quality
kidney	UBERON:0002113	88.66	gold quality
caudate nucleus	UBERON:0001873	88.63	gold quality
putamen	UBERON:0001874	88.51	gold quality
frontal cortex	UBERON:0001870	88.22	gold quality
right atrium auricular region	UBERON:0006631	88.21	gold quality
C1 segment of cervical spinal cord	UBERON:0006469	88.09	gold quality
anterior cingulate cortex	UBERON:0009835	88.09	gold quality
spinal cord	UBERON:0002240	88.08	gold quality
pancreas	UBERON:0001264	87.99	gold quality
superior frontal gyrus	UBERON:0002661	87.91	gold quality
prefrontal cortex	UBERON:0000451	87.82	gold quality
right adrenal gland cortex	UBERON:0035827	87.71	gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

Experiment	Marker?	Max mean expression
E-MTAB-6379	no	7.98
E-ANND-3	no	2.20

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

43 targeting SLC2A11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-4795-3P	100.00	74.62	4024
HSA-MIR-126-5P	100.00	72.71	3180
HSA-MIR-3924	100.00	72.09	2394
HSA-MIR-1277-5P	100.00	73.95	5056
HSA-MIR-6748-5P	100.00	65.81	1057
HSA-MIR-4282	99.99	75.36	6408
HSA-MIR-223-3P	99.99	70.14	1140
HSA-MIR-568	99.98	69.86	2084
HSA-MIR-6793-5P	99.97	65.95	758
HSA-MIR-6778-3P	99.96	67.29	2693
HSA-MIR-101-3P	99.94	75.03	2230
HSA-MIR-9983-3P	99.94	71.48	3631
HSA-MIR-95-5P	99.89	72.17	3973
HSA-MIR-944	99.82	70.85	3042
HSA-MIR-4307	99.82	70.45	3374
HSA-MIR-1200	99.71	70.42	1838
HSA-MIR-33A-3P	99.70	70.27	3362
HSA-MIR-3177-5P	99.65	70.38	1174
HSA-MIR-1827	99.63	68.57	3265
HSA-MIR-4743-3P	99.62	68.12	2095
HSA-MIR-510-3P	99.54	70.06	2965
HSA-MIR-7158-5P	99.25	67.95	796
HSA-MIR-6878-3P	99.24	64.23	920
HSA-MIR-4777-3P	99.15	68.92	626
HSA-MIR-10B-3P	99.04	66.98	988
HSA-MIR-6506-5P	99.04	65.66	1386
HSA-MIR-7151-3P	99.04	69.72	2370
HSA-MIR-4650-3P	99.01	68.39	1062
HSA-MIR-1304-5P	98.90	68.58	1054
HSA-MIR-3190-5P	98.87	64.89	1345

Literature-anchored findings (GeneRIF, showing 4)

• a novel sugar transporter that is alternatively spliced in various tissues (PMID:12175779)
• Different promoters and splicing generate three SLC2A11 isoforms which are expressed in a tissue specific manner but do not appear to differ in their functional characteristics. (PMID:16154905)
• GLUT11 can also transport fructose, but it has the motif DSV at the same position, which appears to function in the same manner as NXI and when all three residues are replaced with NAV fructose transport lost. (PMID:17710649)
• Critical roles for novel GLUT family members highlight a therapeutic strategy entailing selective GLUT inhibition to specifically target aberrant glucose metabolism in cancer. (PMID:22452979)

Cross-species orthologs

43 orthologs

Organism	Symbol	Gene ID
danio_rerio	slc2a11a	ENSDARG00000053961
drosophila_melanogaster	Glut3	FBGN0015230
drosophila_melanogaster	sut4	FBGN0028560
drosophila_melanogaster	sut3	FBGN0028561
drosophila_melanogaster	sut2	FBGN0028562
drosophila_melanogaster	sut1	FBGN0028563
drosophila_melanogaster	CG4607	FBGN0029932
drosophila_melanogaster	CG15406	FBGN0031517
drosophila_melanogaster	CG8837	FBGN0031520
drosophila_melanogaster	CG3285	FBGN0031522
drosophila_melanogaster	CG15408	FBGN0031523
drosophila_melanogaster	CG7882	FBGN0033047
drosophila_melanogaster	Tret1-2	FBGN0033644
drosophila_melanogaster	CG8249	FBGN0034045
drosophila_melanogaster	CG6484	FBGN0034247
drosophila_melanogaster	CG14160	FBGN0036066
drosophila_melanogaster	nebu	FBGN0036316
drosophila_melanogaster	CG1208	FBGN0037386
drosophila_melanogaster	CG14606	FBGN0037485
drosophila_melanogaster	CG14605	FBGN0037486
drosophila_melanogaster	CG6901	FBGN0038414
drosophila_melanogaster	CG17929	FBGN0038415
drosophila_melanogaster	CG17930	FBGN0038416
drosophila_melanogaster	Tret1-1	FBGN0050035
drosophila_melanogaster	CG32053	FBGN0052053
drosophila_melanogaster	CG32054	FBGN0052054
drosophila_melanogaster	CG33281	FBGN0053281
drosophila_melanogaster	CG33282	FBGN0053282
drosophila_melanogaster	Srg2	FBGN0262007
drosophila_melanogaster	CG42826	FBGN0262008
caenorhabditis_elegans		WBGENE00008730
caenorhabditis_elegans		WBGENE00010684
caenorhabditis_elegans		WBGENE00010811
caenorhabditis_elegans		WBGENE00012536
caenorhabditis_elegans		WBGENE00013074
caenorhabditis_elegans		WBGENE00016431
caenorhabditis_elegans		WBGENE00017382
caenorhabditis_elegans		WBGENE00019207
caenorhabditis_elegans		WBGENE00019547
caenorhabditis_elegans		WBGENE00019548
caenorhabditis_elegans		WBGENE00019549
caenorhabditis_elegans		WBGENE00019550
caenorhabditis_elegans		WBGENE00043980

Paralogs (13): SLC2A3 (ENSG00000059804), SLC2A9 (ENSG00000109667), SLC2A1 (ENSG00000117394), SLC2A8 (ENSG00000136856), SLC2A5 (ENSG00000142583), SLC2A12 (ENSG00000146411), SLC2A13 (ENSG00000151229), SLC2A6 (ENSG00000160326), SLC2A2 (ENSG00000163581), SLC2A14 (ENSG00000173262), SLC2A4 (ENSG00000181856), SLC2A7 (ENSG00000197241), SLC2A10 (ENSG00000197496)

Protein

Protein identifiers

Solute carrier family 2, facilitated glucose transporter member 11 — Q9BYW1 (reviewed: Q9BYW1)

Alternative names: Glucose transporter type 11

All UniProt accessions (9): A0A087X018, B5MCM1, B5MCM7, Q9BYW1, F8WB79, F8WBG9, F8WBK0, F8WCV3, F8WFA8

UniProt curated annotations — full annotation on UniProt →

Function. Facilitative glucose transporter.

Subcellular location. Cell membrane.

Tissue specificity. Expressed in heart and skeletal muscle.

Similarity. Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. Glucose transporter subfamily.

Isoforms (4)

UniProt ID	Names	Canonical?
Q9BYW1-1	1	yes
Q9BYW1-2	2, GLUT11-s
Q9BYW1-3	3
Q9BYW1-4	4, GLUT11-L

RefSeq proteins (4): NP_001020109, NP_001020110, NP_001269793, NP_110434 (=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR003663	Sugar/inositol_transpt	Family
IPR005828	MFS_sugar_transport-like	Family
IPR005829	Sugar_transporter_CS	Conserved_site
IPR020846	MFS_dom	Domain
IPR036259	MFS_trans_sf	Homologous_superfamily
IPR045263	GLUT	Family

Pfam: PF00083

Catalyzed reactions (Rhea), 1 shown:

• D-glucose(out) = D-glucose(in) (RHEA:60376)

UniProt features (37 total): topological domain 13, transmembrane region 12, sequence variant 5, splice variant 4, chain 1, glycosylation site 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-Q9BYW1-F1	88.14	0.62

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 47

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

ID	Pathway
R-HSA-189200	Cellular hexose transport

MSigDB gene sets: 64 (showing top): GOBP_CARBOHYDRATE_TRANSPORT, GOBP_D_GLUCOSE_IMPORT, GOBP_ORGANIC_ANION_TRANSPORT, GOBP_VITAMIN_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, GOMF_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP, GOMF_TRANSPORTER_ACTIVITY, GOMF_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, REACTOME_CELLULAR_HEXOSE_TRANSPORT, REACTOME_TRANSPORT_OF_SMALL_MOLECULES, MTOR_UP.N4.V1_DN, GOBP_DEHYDROASCORBIC_ACID_TRANSPORT, NPAT_TARGET_GENES, ZNF563_TARGET_GENES

GO Biological Process (7): hexose transmembrane transport (GO:0008645), fructose transmembrane transport (GO:0015755), obsolete D-glucose import (GO:0046323), dehydroascorbic acid transport (GO:0070837), D-glucose transmembrane transport (GO:1904659), transmembrane transport (GO:0055085), fructose import across plasma membrane (GO:1990539)

GO Molecular Function (5): fructose transmembrane transporter activity (GO:0005353), sugar transmembrane transporter activity (GO:0051119), D-glucose transmembrane transporter activity (GO:0055056), hexose transmembrane transporter activity (GO:0015149), transmembrane transporter activity (GO:0022857)

GO Cellular Component (5): nucleoplasm (GO:0005654), plasma membrane (GO:0005886), cell junction (GO:0030054), membrane (GO:0016020), sarcolemma (GO:0042383)

Reactome top-level categories

Rollup of top-1 pathways:

Category	Pathways
SLC-mediated transmembrane transport	1

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
hexose transmembrane transport	3
cellular anatomical structure	3
fructose transmembrane transport	2
hexose transmembrane transporter activity	2
monosaccharide transmembrane transport	1
vitamin transport	1
transport	1
cellular process	1
hexose import across plasma membrane	1
carbohydrate transmembrane transporter activity	1
monosaccharide transmembrane transporter activity	1
transporter activity	1
transmembrane transport	1
nuclear lumen	1
membrane	1
cell periphery	1
plasma membrane	1

Protein interactions and networks

STRING

686 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
SLC2A11	SLC5A4	Q9NY91	536
SLC2A11	SLC5A9	Q2M3M2	501
SLC2A11	SLC5A1	P13866	454
SLC2A11	LRRC75B	Q2VPJ9	417
SLC2A11	ARL8B	Q9NVJ2	396
SLC2A11	SLC2A12	Q8TD20	393
SLC2A11	C22orf15	Q8WYQ4	392
SLC2A11	SLC5A11	Q8WWX8	385
SLC2A11	SLC2A8	Q9NY64	380
SLC2A11	SLC2A6	Q9UGQ3	377
SLC2A11	NDUFA8	P51970	376
SLC2A11	MSI2	Q96DH6	375
SLC2A11	MSI1	O43347	364
SLC2A11	SLC5A10	A0PJK1	358
SLC2A11	H7C0V5	H7C0V5	354

IntAct

3 interactions, top by confidence:

A	B	Type	Score
ARRDC1	WWP2	psi-mi:“MI:0914”(association)	0.850
SLC2A11	SEC24B	psi-mi:“MI:0914”(association)	0.350

BioGRID (14): SLC2A11 (Affinity Capture-RNA), SLC2A11 (Affinity Capture-MS), CLPB (Affinity Capture-MS), DNAJC18 (Affinity Capture-MS), DNAJC7 (Affinity Capture-MS), FAM189B (Affinity Capture-MS), FZD8 (Affinity Capture-MS), GOLGA2 (Affinity Capture-MS), NDFIP1 (Affinity Capture-MS), PBXIP1 (Affinity Capture-MS), SEC23A (Affinity Capture-MS), SEC23B (Affinity Capture-MS), SEC24B (Affinity Capture-MS), VANGL1 (Affinity Capture-MS)

ESM2 similar proteins: A0A3Q2IDB4, A0A8B7HA97, A4ZYQ5, A6NK97, G1SZD9, O35956, O57379, O88909, P22732, P23945, P43427, Q0IHM1, Q2KIV1, Q3ZAV1, Q4U2R8, Q4W8A2, Q4W8A3, Q5R9C4, Q5RC45, Q5RCH6, Q5RET7, Q63ZE4, Q66J52, Q6DFR1, Q6NUB3, Q6NYN7, Q6PXP3, Q6T423, Q70BM6, Q76M72, Q76M99, Q80UJ1, Q863Y9, Q864Z3, Q8CFZ5, Q8HY24, Q8IVM8, Q8MK48, Q8N4F4, Q8R0S9

Diamond homologs: A1Z8N1, A4ZYQ5, A5LGM7, A9ZSY3, B3MG58, B3NSE1, B4HNS0, B4HNS1, B4J913, B4KR05, B4LPX5, B4P624, B4QBN2, B4QBN3, C0SPB2, O44616, O44827, O62786, O62787, P0C6A1, P11166, P11167, P11168, P11169, P12336, P13355, P14142, P14246, P14672, P17809, P19357, P20303, P22732, P27674, P28568, P32037, P32466, P43427, P46333, P46408

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

108 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	81
Likely benign	4
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2389 predictions. Top by Δscore:

Variant	Effect	Δscore
22:23862102:A:AG	acceptor_gain	1.0000
22:23862103:G:GC	acceptor_loss	1.0000
22:23862103:G:GG	acceptor_gain	1.0000
22:23862103:GA:G	acceptor_gain	1.0000
22:23862103:GAT:G	acceptor_gain	1.0000
22:23862103:GATTC:G	acceptor_gain	1.0000
22:23862203:G:GG	donor_gain	1.0000
22:23875097:T:TA	acceptor_gain	1.0000
22:23875099:T:TA	acceptor_gain	1.0000
22:23875105:A:AG	acceptor_gain	1.0000
22:23875106:C:G	acceptor_gain	1.0000
22:23875112:CCAA:C	acceptor_loss	1.0000
22:23875113:CAAG:C	acceptor_loss	1.0000
22:23875114:A:AG	acceptor_gain	1.0000
22:23875114:AAG:A	acceptor_gain	1.0000
22:23875115:A:G	acceptor_gain	1.0000
22:23875115:A:T	acceptor_loss	1.0000
22:23875115:AGGA:A	acceptor_loss	1.0000
22:23875116:G:GG	acceptor_gain	1.0000
22:23875116:GG:G	acceptor_loss	1.0000
22:23875116:GGAA:G	acceptor_gain	1.0000
22:23875215:G:GT	donor_gain	1.0000
22:23875215:G:T	donor_gain	1.0000
22:23875237:TGCAG:T	donor_loss	1.0000
22:23875239:C:T	donor_gain	1.0000
22:23875239:CAG:C	donor_loss	1.0000
22:23875239:CAGG:C	donor_loss	1.0000
22:23875240:AGGTA:A	donor_loss	1.0000
22:23875241:GGTAT:G	donor_loss	1.0000
22:23875242:GTAT:G	donor_loss	1.0000

AlphaMissense

3197 scored. Top likely-pathogenic:

Variant	Protein change	am_pathogenicity
22:23877818:A:C	S212R	0.988
22:23877820:C:A	S212R	0.988
22:23877820:C:G	S212R	0.988
22:23884006:A:C	S382R	0.984
22:23884008:C:A	S382R	0.984
22:23884008:C:G	S382R	0.984
22:23877748:G:C	W188C	0.978
22:23877748:G:T	W188C	0.978
22:23877080:A:C	S149R	0.977
22:23877082:C:A	S149R	0.977
22:23877082:C:G	S149R	0.977
22:23877140:G:A	G169R	0.977
22:23877140:G:C	G169R	0.977
22:23875117:G:C	R94S	0.976
22:23875117:G:T	R94S	0.976
22:23877068:T:G	Y145D	0.976
22:23877746:T:A	W188R	0.972
22:23877746:T:C	W188R	0.972
22:23877764:A:C	S194R	0.972
22:23877766:C:A	S194R	0.972
22:23877766:C:G	S194R	0.972
22:23877152:G:A	G173R	0.971
22:23877152:G:C	G173R	0.971
22:23877141:G:A	G169E	0.970
22:23884009:T:C	F383L	0.970
22:23884011:T:A	F383L	0.970
22:23884011:T:G	F383L	0.970
22:23875178:A:C	S115R	0.967
22:23875180:C:A	S115R	0.967
22:23875180:C:G	S115R	0.967

dbSNP variants (sampled 300 via entrez): RS1000011946 (22:23871603 A>C,G), RS1000094916 (22:23858295 G>T), RS1000246526 (22:23864619 A>G), RS1000274473 (22:23884362 G>A), RS1000338510 (22:23866791 G>A,C), RS1000394722 (22:23869768 T>C), RS1000468259 (22:23869534 C>G,T), RS1000564441 (22:23876194 A>G), RS1000583742 (22:23856400 G>A), RS1000608881 (22:23874561 C>A,G,T), RS1000661699 (22:23880270 A>G), RS1000980920 (22:23874754 A>T), RS1000997408 (22:23876525 G>C), RS1001049098 (22:23859930 G>A,T), RS1001153777 (22:23859296 G>A)

Disease associations

OMIM: gene MIM:610367 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

Study	Trait	p-value
GCST003483_2	S-phenylmercapturic acid levels in smokers	2.000000e-46
GCST012038_5	Sleep duration (> 10 hours)	5.000000e-08

EFO canonical traits (1, from GWAS)

EFO ID	Trait name
EFO:0007651	urinary S-phenylmercapturic acid measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — Class II transporters

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
Cisplatin	increases expression, affects cotreatment	3
Tetrachlorodibenzodioxin	increases expression	3
Benzo(a)pyrene	decreases methylation, increases expression	2
Cadmium Chloride	decreases expression	2
aristolochic acid I	increases expression	1
GSK-J4	decreases expression	1
triphenyl phosphate	affects expression	1
beta-lapachone	increases expression	1
arsenite	affects binding, decreases reaction	1
tris(1,3-dichloro-2-propyl)phosphate	increases expression	1
butyraldehyde	decreases expression	1
gossypol acetic acid	increases expression	1
di-n-butylphosphoric acid	affects expression	1
2,2’,4,4’,5-brominated diphenyl ether	increases expression	1
jinfukang	affects cotreatment, increases expression	1
Zoledronic Acid	decreases expression	1
Leflunomide	increases expression	1
Cidofovir	affects expression	1
Clodronic Acid	increases expression	1
Fructose	increases transport	1
Glucose	increases transport	1
Oxygen	decreases expression	1
Smoke	decreases expression	1
Tobacco Smoke Pollution	decreases expression	1
Zidovudine	increases expression	1
Cyclosporine	decreases expression	1
Okadaic Acid	decreases expression	1
Copper Sulfate	decreases expression	1

Cellosaurus cell lines

4 cell lines: 4 cancer cell line

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_D4L4	HCT116-SLC2A11-KO-c7	Cancer cell line	Male
CVCL_D4L5	HCT116-SLC2A11-KO-c9	Cancer cell line	Male
CVCL_XT12	HAP1 SLC2A11 (-) 1	Cancer cell line	Male
CVCL_XT13	HAP1 SLC2A11 (-) 2	Cancer cell line	Male

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.